|Immunogen:||Recombinant human Galectin-7|
|Application Notes:||Recombinant human Galectin-7 (Cat. #:4647-10) can be used as a positive control. |
|Purity Detail:||Affinity Purified Antibody|
|Formulation:||100 µg (0.5 mg/ml) affinity purified rabbit anti-human Galectin-7 polyclonal antibody in phosphate buffered saline (PBS), pH 7.2, containing 30% glycerol, 0.5% BSA, 0.01% thimerosal.|
|Long Term Storage:||-20°C|
|Miscellaneous/General:||Galectin-7 belongs to growing family of evolutionary conserved animal lectins. Galectins consists of beta-galactoside binding lectins that contain homologous carbohydrate recognition domains (CRDs). Galectin has the ability to induce apoptosis of activated T-cells and T-leukaemia cell lines. Other activities include cell differentiation and inhibition activity of CD45 protein phosphatase activity. Galectin also binds beta-galactoside as well as CD45, CD3 and CD4. Recombinant Human Galectin-7 is a 15.4 kDa protein consisting of 136 amino acid residues.|
|Background / Technical Information:||For the Original Manufacturer's Data Sheet please click here.|
Our product description may differ slightly from the Original Manufacturer's Data Sheet.